Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Harvard Business School
Express Scripts
Moodys
Mallinckrodt

Last Updated: December 6, 2021

DrugPatentWatch Database Preview

Patent: 7,151,114

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 7,151,114
Title:Use of substituted 2-phenylbenzimidazoles as medicaments
Abstract: The present invention relates to the use of a substituted 2-phenylbenzimidazole of formula I ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and m have the meanings given in the claims, for the preparation of a medicament for the treatment or prevention of diseases involving glucagon receptors, as well as new compounds of formula I wherein R.sup.1 is a group of formula ##STR00002##
Inventor(s): Streicher; Ruediger (Biberach, DE), Mack; Juergen (Biberach, DE), Walter; Rainer (Biberach, DE), Konetzki; Ingo (Warthausen, DE), Trieselmann; Thomas (Warthausen, DE), Austel; Volkhard (Biberach, DE)
Assignee: Boehringer Ingelheim International GmbH (Ingelheim, DE)
Application Number:10/744,830
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,151,114
Patent Claims:see list of patent claims

Details for Patent 7,151,114

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Pharmacia & Upjohn Company Llc SOMAVERT pegvisomant For Injection 021106 2003-03-25 ⤷  Free Forever Trial 2023-01-09
Pharmacia & Upjohn Company Llc SOMAVERT pegvisomant For Injection 021106 2014-07-31 ⤷  Free Forever Trial 2023-01-09
Eisai, Incorporated ONTAK denileukin diftitox Injection 103767 1999-02-05 ⤷  Free Forever Trial 2023-01-09
Immunex Corporation ENBREL etanercept For Injection 103795 1998-11-02 ⤷  Free Forever Trial 2023-01-09
Immunex Corporation ENBREL etanercept For Injection 103795 1999-05-27 ⤷  Free Forever Trial 2023-01-09
Immunex Corporation ENBREL etanercept Injection 103795 2004-09-27 ⤷  Free Forever Trial 2023-01-09
Immunex Corporation ENBREL etanercept Injection 103795 2007-02-01 ⤷  Free Forever Trial 2023-01-09
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Dow
Johnson and Johnson
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.